MedTrace Logo

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

NCT06920134 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-11-18

No results posted yet for this study

Summary

The PD-HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support hemodynamic management in people with typical and atypical Parkinson's Disease, who suffer from orthostatic hypotension.

Conditions

  • Hypotension Symptomatic
  • Parkinson's Disease
  • Orthostatic Hypotension, Dysautonomic
  • Multiple System Atrophy (MSA) With Orthostatic Hypotension
  • Multiple System Atrophy - Parkinsonian Subtype (MSA-P)

Interventions

DEVICE

ARC-IM Investigational System

Implantation of a stimulation lead on the low thoracic level of the spinal cord and implantation of a neurostimulator in the abdominal region.

Sponsors & Collaborators

  • Ecole Polytechnique Fédérale de Lausanne

    lead OTHER

Principal Investigators

  • Jocelyne Bloch, MD · CHUV

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-03
Primary Completion
2031-05-01
Completion
2031-05-01

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06920134 on ClinicalTrials.gov